BOTTI, ELISABETTA
 Distribuzione geografica
Continente #
NA - Nord America 8.857
AS - Asia 1.771
EU - Europa 1.350
SA - Sud America 234
AF - Africa 23
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 2
Totale 12.242
Nazione #
US - Stati Uniti d'America 8.798
SG - Singapore 705
CN - Cina 451
RU - Federazione Russa 234
IT - Italia 212
HK - Hong Kong 190
BR - Brasile 188
DE - Germania 180
IE - Irlanda 178
VN - Vietnam 168
UA - Ucraina 125
FR - Francia 115
GB - Regno Unito 63
KR - Corea 62
SE - Svezia 55
FI - Finlandia 53
PL - Polonia 49
JP - Giappone 46
BD - Bangladesh 44
CA - Canada 36
IN - India 24
NL - Olanda 17
BE - Belgio 16
AR - Argentina 15
MX - Messico 13
EC - Ecuador 11
ES - Italia 11
TR - Turchia 10
AT - Austria 9
IQ - Iraq 9
ID - Indonesia 7
UZ - Uzbekistan 7
CL - Cile 5
CZ - Repubblica Ceca 5
KG - Kirghizistan 5
MY - Malesia 5
ZA - Sudafrica 5
CO - Colombia 4
DK - Danimarca 4
EU - Europa 4
JO - Giordania 4
KE - Kenya 4
PH - Filippine 4
PK - Pakistan 4
PY - Paraguay 4
VE - Venezuela 4
AE - Emirati Arabi Uniti 3
EG - Egitto 3
IL - Israele 3
LT - Lituania 3
MA - Marocco 3
MD - Moldavia 3
NP - Nepal 3
RO - Romania 3
RS - Serbia 3
TH - Thailandia 3
AZ - Azerbaigian 2
CY - Cipro 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
ET - Etiopia 2
HN - Honduras 2
HR - Croazia 2
HU - Ungheria 2
OM - Oman 2
PE - Perù 2
PT - Portogallo 2
TW - Taiwan 2
VC - Saint Vincent e Grenadine 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AD - Andorra 1
AL - Albania 1
AM - Armenia 1
AU - Australia 1
BB - Barbados 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CU - Cuba 1
GA - Gabon 1
GR - Grecia 1
IR - Iran 1
JM - Giamaica 1
LK - Sri Lanka 1
MO - Macao, regione amministrativa speciale della Cina 1
NG - Nigeria 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
SA - Arabia Saudita 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
Totale 12.242
Città #
Wilmington 1.814
Houston 1.791
Woodbridge 1.411
Fairfield 489
Singapore 426
Chandler 422
Ashburn 297
Ann Arbor 295
Seattle 222
Beijing 204
San Jose 192
Hong Kong 184
Cambridge 176
Dublin 163
Medford 124
Dearborn 119
New York 109
Jacksonville 84
Rome 73
Santa Clara 71
The Dalles 68
Los Angeles 64
Lawrence 57
Hanoi 46
Lauterbourg 46
Council Bluffs 45
Ho Chi Minh City 43
Tokyo 42
Moscow 38
Dallas 37
Kraków 35
Helsinki 33
Munich 31
San Diego 31
Buffalo 29
São Paulo 29
Turin 20
Redwood City 17
Boardman 16
Guangzhou 16
Atlanta 14
Brussels 14
Shanghai 13
Nuremberg 12
Zhengzhou 12
Chicago 11
Da Nang 11
Milan 11
Nanjing 11
Kunming 10
Montreal 10
Warsaw 10
Denver 9
London 9
Manchester 9
Orem 9
Redondo Beach 9
Stockholm 9
Toronto 9
Chennai 8
Mülheim 8
Brooklyn 7
Hefei 7
Jinan 7
Menlo Park 7
Norwalk 7
Poplar 7
San Francisco 7
Wuhan 7
Frankfurt am Main 6
Mountain View 6
Paris 6
San Mateo 6
Amsterdam 5
Curitiba 5
Falls Church 5
Hounslow 5
Nha Trang 5
North Bergen 5
Phoenix 5
Pune 5
Quito 5
Saint Louis 5
Salt Lake City 5
Utrecht 5
Vancouver 5
Amman 4
Ankara 4
Biên Hòa 4
Boston 4
Bắc Giang 4
Cagliari 4
Cangzhou 4
Casarile 4
Centrale 4
Chengdu 4
Columbus 4
Dhaka 4
Espoo 4
Genoa 4
Totale 9.828
Nome #
Sox2 is not required for melanomagenesis, melanoma growth and melanoma metastasis in vivo 561
Functionalized gold nanoparticles for topical delivery of methotrexate for the possible treatment of psoriasis 526
Involvement of interleukin-21 in the epidermal hyperplasia of psoriasis 500
IL-21 Promotes Skin Recruitment of CD4+ Cells and Drives IFN- -Dependent Epidermal Hyperplasia 489
IL-21 in the pathogenesis and treatment of skin diseases 445
Psoriasis, from pathogenesis to therapeutic strategies: IL-21 as a novel potential therapeutic target 440
Efficacy of short-term cyclosporine treatment to control psoriasis-related events during efalizumab therapy 438
S100A8/A9 in psoriatic plaques from patients with psoriatic arthritis 417
The tumor suppressor activity of IKK alpha in stratified epithelia is exerted in part via the TGF-beta anti proliferative pathway 407
Clindamycin versus clindamycin plus rifampicin in Hidradenitis Suppurativa treatment: clinical and ultrasound observations 393
Severe erytrodermic psoriasis in child twins: From clinical-pathological diagnosis to treatment of choice through genetic analyses: Two case reports 382
Anti-LL37 antibodies are present in psoriatic arthritis (PsA) patients: New biomarkers in PsA 360
IL-21, a new player in pathogenesis of psoriasis 356
Effects of topical methotrexate loaded gold nanoparticle in cutaneous inflammatory mouse model 344
CXCL4 assembles DNA into liquid crystalline complexes to amplify TLR9-mediated interferon-α production in systemic sclerosis 344
Potential Role of Cytochrome c and Tryptase in Psoriasis and Psoriatic Arthritis Pathogenesis: Focus on Resistance to Apoptosis and Oxidative Stress 298
Long-term efficacy and safety of adalimumab on a severe case of Hidradenitis Suppurativa 288
Bowel-associated dermatosis arthritis syndrome and palisading neutrophilic granulomatous dermatitis as presentation of ulcerative colitis 259
A regulatory feedback loop involving p63 and IRF6 links the pathogenesis of 2 genetically different human ectodermal dysplasias 216
Cutaneous mastocytosis: a dermatological perspective 208
The combined role of clinical, reflectance confocal microscopy and dermoscopy applied to chronic discoid cutaneous lupus and subacutus lupus erythematosus: a case series and literature review 185
Native/citrullinated LL37-specific T-cells help autoantibody production in Systemic Lupus Erythematosus 184
Detection of adalimumab and anti-adalimumab levels by ELISA: clinical considerations 178
Efficacy of efalizumab in psoriasis patients previously treated with tumour necrosis factor blockers 175
Vulvar basal cell carcinoma, so rare? 161
Long-term treatment of plaque psoriasis with efalizumab: an Italian experience 160
Developmental factor IRF6 exhibits tumor suppressor activity in squamous cell carcinomas 152
The antimicrobial peptide LL37 is a T-cell autoantigen in psoriasis 151
Genetic markers predictive of clinical response to biological drugs in psoriasis. 145
Nanomedicine in dermatology: Benefits and emerging applications 145
Allele-specific cytokine responses at the HLA-C locus: Implications for psoriasis 144
Dimethylfumarate efficacy and safety in palmoplantar psoriasis patient affected by hepatitis b and depression: A case report 143
Confocal, wide band spectral reflection microscope, and relevant spectral imaging method 141
Pharmacogenetics of psoriasis: HLA-Cw6 but not LCE3B/3C deletion nor TNFAIP3 polymorphism predisposes to clinical response to interleukin 12/23 blocker ustekinumab 140
Suicide risk and psychiatric comorbidity in patients with psoriasis. 139
Investigating the expression of the susceptibility allele HLA-Cw6 in psoriasis using a specific single chain fragment antibody 137
Genetic variations in IL6 and IL12B decreasing the risk for psoriasis 133
p53 promuove la progressione tumorale nelle cellule di melamona resistenti agli inibitori di BRAF 131
Patients with moderate to severe plaque psoriasis: One year after the European medicines agency recommendation of efalizumab suspension 131
IL12B (p40) Gene Polymorphisms Contribute to Ustekinumab Response Prediction in Psoriasis 129
Etanercept reverses downregulation of inhibitor of nuclear factor kappa-B kinase subunit alpha (IKKa) in psoriasis 125
HLA-Cw6 allele confers sensitivity to efalizumab treatment in psoriasis 121
Targeted therapy in nonmelanoma skin cancers 116
Assessing the expression of HLA-Cw6 using specific single chain antibody (scFv) 113
A Longitudinal Multiinstitutional Study of Vulvar Lichen Sclerosus: From Childhood to Perimenopause 107
TRIM8 and p53: Making the right decision 106
Living matter observations with a novel hyperspectral supercontinuum confocal microscope for VIS to near-IR reflectance spectroscopy 105
Programmed cell death in the skin 101
Human leucocyte antigen Cw6 predisposes to clinical response to the inlterleukin-12/23 blocker ustekinumab: results of long-term treatment 98
Label-free and non-invasive discrimination of HaCaT and melanoma cells in a co-culture model by hyperspectral confocal reflectance microscopy 96
Cw6 but not allele LCE3C_LCE3B deletion confers sensitivity to ustekinumab treatment in psoriasis 92
Next generation sequencing technology to explore anti-inflammatory activity of IKKa in psoriasis 85
Use of brodalumab for the treatment of chronic plaque psoriasis: a one-year real-life study in the Lazio region, Italy 76
HLA-C*06:02 allele can influence clinical efficacy of certolizumab pegol? 73
Genetic variations in IL6 and IL12B as protective markers for psoriasis 70
TP63 and TP73 in cancer, an unresolved "family" puzzle of complexity, redundancy and hierarchy 69
Genetic variati ons in IL6 and IL12B as protecti ve markers for psoriasis Abstracts of the 2013 International Investigative Dermatology Meeting. May 8-11, 2013. Edinburgh, Scotland, United Kingdom 68
HLACw6 predisposes to clinical response to IL12/23 blocker ustekinumab: Results of short- and long-term treatment in anti-TNF naïve patients 68
Usefulness of topical imiquimod 3.75% in cytokeratin 7 positive extramammary paget disease of the vulva: towards personalized therapy 62
Potential role of HLA-Cw6 in clinical response to anti-tumour necrosis factor alpha and t-cell targeting agents in psoriasis patients 58
Totale 12.484
Categoria #
all - tutte 38.199
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.199


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022570 23 62 17 23 18 36 45 23 38 53 55 177
2022/2023845 91 81 73 108 56 210 57 43 82 5 31 8
2023/2024314 34 7 19 7 32 95 12 29 4 8 9 58
2024/20251.170 66 240 122 95 13 71 114 54 82 100 76 137
2025/20262.179 176 101 251 222 215 82 326 213 225 197 105 66
2026/202714 14 0 0 0 0 0 0 0 0 0 0 0
Totale 12.484